Free Trial
TSE:EXE

Extendicare (EXE) Stock Price, News & Analysis

Extendicare logo
C$13.63 +0.22 (+1.64%)
As of 11:47 AM Eastern

About Extendicare Stock (TSE:EXE)

Key Stats

Today's Range
C$13.53
C$13.75
50-Day Range
C$13.38
C$14.73
52-Week Range
C$7.20
C$15.24
Volume
126,417 shs
Average Volume
182,054 shs
Market Capitalization
C$1.14 billion
P/E Ratio
17.38
Dividend Yield
3.52%
Price Target
C$13.50
Consensus Rating
Hold

Company Overview

Extendicare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
12th Percentile Overall Score

EXE MarketRank™: 

Extendicare scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Extendicare has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Extendicare has only been the subject of 1 research reports in the past 90 days.

  • Read more about Extendicare's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Extendicare is 17.10, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.91.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Extendicare is 17.10, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.97.

  • Price to Book Value per Share Ratio

    Extendicare has a P/B Ratio of 9.61. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for EXE.
  • Dividend Leadership

    Extendicare is a leading dividend payer. It pays a dividend yield of 4.42%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Extendicare does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Extendicare is 61.20%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about Extendicare's dividend.
  • Short Interest

    There is no current short interest data available for EXE.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Extendicare this week, compared to 1 article on an average week.
  • Search Interest

    Only 7 people have searched for EXE on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Extendicare insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    13.92% of the stock of Extendicare is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 19.16% of the stock of Extendicare is held by institutions.

  • Read more about Extendicare's insider trading history.
Receive EXE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter.

EXE Stock News Headlines

Public market insider buying at Extendicare (EXE)
"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
See More Headlines

EXE Stock Analysis - Frequently Asked Questions

Extendicare's stock was trading at C$10.63 at the beginning of 2025. Since then, EXE stock has increased by 26.2% and is now trading at C$13.41.

Extendicare Inc. (TSE:EXE) announced its quarterly earnings results on Tuesday, November, 12th. The company reported $0.19 earnings per share (EPS) for the quarter. Extendicare had a net margin of 4.48% and a trailing twelve-month return on equity of 64.13%.
Read the conference call transcript
.

Shares of EXE stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Extendicare investors own include Enbridge (ENB), Enterprise Products Partners (EPD), Algonquin Power & Utilities (AQN), Bank of Nova Scotia (BNS), NVIDIA (NVDA), Pembina Pipeline (PPL) and BCE (BCE).

Company Calendar

Last Earnings
11/12/2024
Ex-Dividend for 6/16 Dividend
5/30/2025
Record date for 6/16 Dividend
6/16/2025
Dividend Payable
6/16/2025
Ex-Dividend for 7/15 Dividend
6/30/2025
Today
7/09/2025
Record date for 7/15 Dividend
7/15/2025
Dividend Payable
7/15/2025

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Medical Care Facilities
Sub-Industry
N/A
Current Symbol
TSE:EXE
CIK
N/A
Fax
N/A
Employees
23,000
Year Founded
N/A

Price Target and Rating

High Price Target
C$15.00
Low Price Target
C$11.00
Potential Upside/Downside
+0.7%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
17.10
Forward P/E Ratio
21.86
P/E Growth
N/A
Net Income
C$65.46 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$1.46 billion
Cash Flow
C$4.19 per share
Price / Cash Flow
3.20
Book Value
C$1.40 per share
Price / Book
9.61

Miscellaneous

Free Float
N/A
Market Cap
C$1.12 billion
Optionable
Not Optionable
Beta
1.26
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (TSE:EXE) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners